Bill Maher Slams Google, Facebook for Censoring Content ThatDoesn’t Align With Government-Sanctioned COVID Narrative

Visit Source:  https://childrenshealthdefense.org/defender/bill-maher-google-facebook-censoring-content-government-covid-narrative/ Retrieved:  2021-07-24 22:05:39 Bill Maher said in a video that YouTube has no business censoring information on COVID treatments like ivermectin, or evidence that the SARS-CoV2 may have escaped from a lab. The Defender is experiencing censorship on many social channels. Be sure to stay in touch with the news that matters … Read more

Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7410805/ Am J Med. 2021 Jan; 134(1): 16–22. Published online 2020 Aug 7. doi: 10.1016/j.amjmed.2020.07.003 PMCID: PMC7410805 PMID: 32771461 Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection Peter A. McCullough, MD, MPH,a,b,c,⁎ Ronan J. Kelly, MD,a Gaetano Ruocco, MD,d Edgar Lerma, MD,e James Tumlin, MD,f Kevin R. Wheelan, MD,a,b,c Nevin Katz, MD,g Norman E. Lepor, MD,h Kris Vijay, MD,i Harvey Carter, MD,j Bhupinder Singh, MD,k Sean P. … Read more

He’s Culpable. He’s Lying About It. And He Needs to Be Held Accountable” – Sen. Ron Johnson Says It’s Time to Go After Fauci for Funding Gain-of-Function Research, Lying About It Under Oath (VIDEO)

 

Compelling Case Against COVID ‘Vaccine’ Approval

Compelling Case Against COVID ‘Vaccine’ Approval

American Journal of Therapeutics: Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19

https://journals.lww.com/americantherapeutics/Fulltext/2021/06000/Review_of_the_Emerging_Evidence_Demonstrating_the.4.aspx   Abstract Background: After COVID-19 emerged on U.S shores, providers began reviewing the emerging basic science, translational, and clinical data to identify potentially effective treatment options. In addition, a multitude of both novel and repurposed therapeutic agents were used empirically and studied within clinical trials. Areas of Uncertainty: The majority of trialed agents have … Read more